Johan Bylund

Title: Inventor Profile: Johan Bylund

Introduction

Johan Bylund is an innovative inventor based in Therwil, Switzerland. With a focus on the development of specialized compounds, he holds a total of two patents that contribute to advancements in medicine, particularly in the treatment of pain, inflammation, and cancer.

Latest Patents

Johan Bylund's latest patents revolve around bis(sulfonamide) derivatives and their use as mPGES inhibitors. These patents describe bis(sulfonamide) compounds and their pharmaceutically acceptable salts. The inventions also cover pharmaceutical compositions containing these compounds and their application as medicaments for diseases, disorders, or conditions that would benefit from the modulation of microsomal prostaglandin E synthase-1 activity.

Career Highlights

Throughout his career, Johan has worked with companies such as Arcturum Real Estate AB and Acturum Real Estate AB. His experience in these organizations has likely contributed to his innovative capabilities in developing pharmaceutical compounds.

Collaborations

In his professional journey, Johan has collaborated with notable coworkers including Peter Söderman and Mats A Svensson. These partnerships may have facilitated the exchange of ideas and skills that are essential in the field of pharmaceutical innovation.

Conclusion

Johan Bylund is a commendable inventor whose work on bis(sulfonamide) derivatives showcases his contributions to the medical field. His patents exemplify the potential of innovative compounds in addressing significant health issues, and his collaborations reflect a strong network within the industry.